Federated Hermes’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-84
| Closed | -$1.18K | – | 2028 |
|
|
2024
Q1 | $1.18K | Buy |
+84
| New | +$1.18K | ﹤0.01% | 1950 |
|
|
2022
Q1 | – | Sell |
-64
| Closed | -$1K | – | 2189 |
|
|
2021
Q4 | $1K | Buy |
64
+26
| +68% | +$406 | ﹤0.01% | 2087 |
|
|
2021
Q3 | $1K | Sell |
38
-1
| -3% | -$26 | ﹤0.01% | 2122 |
|
|
2021
Q2 | $1K | Buy |
+39
| New | +$1K | ﹤0.01% | 2113 |
|
|
2020
Q4 | – | Sell |
-507,967
| Closed | -$18.9M | – | 2240 |
|
|
2020
Q3 | $18.9M | Hold |
507,967
| – | – | 0.04% | 419 |
|
|
2020
Q2 | $19.6M | Hold |
507,967
| – | – | 0.05% | 397 |
|
|
2020
Q1 | $12.6M | Buy |
507,967
+154,167
| +44% | +$3.84M | 0.04% | 425 |
|
|
2019
Q4 | $12.5M | Sell |
353,800
-11,100
| -3% | -$394K | 0.03% | 544 |
|
|
2019
Q3 | $11.8M | Hold |
364,900
| – | – | 0.03% | 518 |
|
|
2019
Q2 | $17.7M | Hold |
364,900
| – | – | 0.04% | 380 |
|
|
2019
Q1 | $17.3M | Buy |
364,900
+191,000
| +110% | +$9.08M | 0.04% | 379 |
|
|
2018
Q4 | $4.56M | Hold |
173,900
| – | – | 0.01% | 758 |
|
|
2018
Q3 | $8.35M | Hold |
173,900
| – | – | 0.02% | 635 |
|
|
2018
Q2 | $10M | Buy |
+173,900
| New | +$10M | 0.03% | 451 |
|
|
2017
Q1 | – | Sell |
-2,667
| Closed | -$578K | – | 2114 |
|
|
2016
Q4 | $578K | Buy |
2,667
+829
| +45% | +$180K | ﹤0.01% | 1265 |
|
|
2016
Q3 | $679K | Sell |
1,838
-162
| -8% | -$59.8K | ﹤0.01% | 1200 |
|
|
2016
Q2 | $444K | Hold |
2,000
| – | – | ﹤0.01% | 1306 |
|
|
2016
Q1 | $605K | Buy |
2,000
+667
| +50% | +$202K | ﹤0.01% | 1226 |
|
|
2015
Q4 | $634K | Buy |
1,333
+500
| +60% | +$238K | ﹤0.01% | 1221 |
|
|
2015
Q3 | $405K | Hold |
833
| – | – | ﹤0.01% | 1336 |
|
|
2015
Q2 | $611K | Buy |
+833
| New | +$611K | ﹤0.01% | 1280 |
|